| Predicate |
Object |
| contentType |
Journal Article|Review |
| endingPage |
74 |
| issn |
0920-1211 |
| issueIdentifier |
1 |
| pageRange |
73-74 |
| publicationName |
Epilepsy Research |
| startingPage |
73 |
| bibliographicCitation |
Perucca E. Active control trials: endpoints beyond conventional efficacy and tolerability measures. Epilepsy Res. 2006 Jan;68(1):73–4. doi: 10.1016/j.eplepsyres.2005.09.026. PMID: 16377152. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_980f12f3c9c987a1be8d6e28e4f18ee9 |
| date |
200601 |
| identifier |
https://doi.org/10.1016/j.eplepsyres.2005.09.026
https://pubmed.ncbi.nlm.nih.gov/16377152 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587
https://portal.issn.org/resource/ISSN/0920-1211 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/ |
| title |
Active control trials: Endpoints beyond conventional efficacy and tolerability measures |
| discusses |
http://id.nlm.nih.gov/mesh/M0001382 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D000927Q000627
http://id.nlm.nih.gov/mesh/D004827Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D003071Q000187
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D000927Q000493
http://id.nlm.nih.gov/mesh/D017063Q000379
http://id.nlm.nih.gov/mesh/D000339Q000187 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9251
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907 |